CHAMPIONS ONCOLOGY, INC. (CSBR) Operating margin 2018–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) operating margin by fiscal year — reported operating income divided by reported revenue.
-1.9%FY2026 · since FY2018: -6.7% → -1.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -1.9% | -9.9 pp |
| FY2025 | 8.0% | +22.7 pp |
| FY2024 | -14.7% | -4.9 pp |
| FY2023 | -9.8% | -11.0 pp |
| FY2022 | 1.2% | +0.3 pp |
| FY2021 | 0.9% | +6.9 pp |
| FY2020 | -6.0% | -7.0 pp |
| FY2019 | 1.0% | +7.7 pp |
| FY2018 | -6.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CSBR financial trends
CSBR RevenueCSBR Net incomeCSBR Net marginCSBR Gross profitCSBR Gross marginCSBR Operating incomeCSBR Operating cash flowCSBR Free cash flowCSBR Capital expendituresCSBR Return on equityCSBR Stock buybacksCSBR Dividends paidCSBR Total assetsCSBR Total liabilitiesCSBR Shareholders’ equityCSBR overview →